Blastoma

🛡️ Just a quick check We’re checking your connection to prevent automated abuse Read More

Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Trogenix has developed a platform for generating ‘synthetic super-enhancers’ that could drive highly cell-specific gene therapy-based treatment of solid tumors such as glioblastoma. Author information Authors and Affiliations Philadelphia, PA, USA Michael Eisenstein Authors Michael…

A new preclinical study suggests an experimental mRNA vaccine could help the immune system fight neuroblastoma, one of the deadliest childhood cancers. Credit: Stock An experimental mRNA vaccine delayed neuroblastoma growth and sharply reduced tumor size in preclinical models. The success of mRNA vaccines during the COVID-19 pandemic sparked interest…

Following the American Society of Neuroradiology (ASNR) meeting, MedPage Today convened three leaders in neuro-oncology and brain tumor imaging for a virtual roundtable discussion on the evolving role of advanced MRI in brain tumor care. Moderator Suyash Mohan, MD, of the University of Pennsylvania in Philadelphia, is joined by Caroline…

For months, Edward (Ed) Waldner knew something wasn't right. At 55 years old, he felt constantly drained, no matter how much or how little he had done during the day. He wondered whether sleep apnea might be to blame. He also noticed subtle changes in the way he walked, including…

Proceedings of the National Academy of Sciences, Volume 123, Issue 25, June 2026. SignificanceICAM-1/LFA-1 interactions enhance immune cell avidity, stabilizing immune synapses and improving cytotoxicity in solid tumors. The IFNγ signaling pathway was found to be essential for ICAM1 upregulation. Here, we revealed in glioblastoma that ...Read More

Published : , ,   Dr. Chae-Yong Kim of Seoul National University Bundang Hospital delivers oral presentation on interim data from 10 enrolled patients A manageable safety profile, with prolonged disease control and tumor recurrence inhibition observed in several patients SEONGNAM and SEOUL, South Korea, June 15, 2026 /PRNewswire/ --…

🛡️ Just a quick check We’re checking your connection to prevent automated abuse Read More

Please enable JS and disable any ad blocker Read More

You're visiting this site from a location that is not currently supported. We are working on expanding access to usatoday.com and we appreciate your interest and patience. Read More